| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H27N3O4S2 |
| Molecular Weight | 377.523 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)NCCN(C(C)C)S(=O)(=O)C1=CC=C(NS(C)(=O)=O)C=C1
InChI
InChIKey=GLIRXHQYWRYQDV-UHFFFAOYSA-N
InChI=1S/C15H27N3O4S2/c1-12(2)16-10-11-18(13(3)4)24(21,22)15-8-6-14(7-9-15)17-23(5,19)20/h6-9,12-13,16-17H,10-11H2,1-5H3
Risotilide is a Class III antiarrhythmic agent that inhibits the voltage-dependent potassium channel. Risotilide prolongs cardiac action potentials and refractory periods. It was shown to reduce ventricular vulnerability in a study on arrhythmogenic effects of left ventricular hypertrophy (LVH) in the intact heart in cats. Phase I and II trials have been conducted, but development of this drug has been discontinued.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Patents
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
